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Pediatric TB provides unique opportunities to study TB
disease epidemiology. Improved diagnostics are of key
importance in order to address many of the challenges
posed by TB in children. In the Western Cape Province
in South Africa, the TB notification rate was more than
600 out of 100,000 for children aged 0-14 years in 2007;
the maternal HIV prevalence was 15%, with a good ver-
tical preventative program. The HIV transmission rate
was 4-5%; 99% of neonates routinely receive BCG vacci-
nation at birth. Isoniazid prophylaxis, shown to be effec-
tive in the prevention of TB in young children, is
seldom initiated and many missed opportunities for pre-
ventive therapy exist. In children admitted to hospital,
mycobacterial culture is routinely done for TB in chil-
dren less than five years of age through gastric aspira-
tion of stomach contents in this setting; the culture
yield is 30-40% in children with clinically suspected TB.
In a recent study of infants admitted to the three Cape
Town hospitals over a three-year period, 55% of chil-
dren born to HIV positive mothers had a household
contact with TB, indicating a high level of TB exposure.
A high risk of serious BCG vaccine complications exists
in HIV-positive infants in the form of disseminated
BCG disease, with an incidence of 992 per 100 000 (95%
CI: 567-1495). More research is needed to determine if
BCG vaccination protects against TB in infants born to
HIV-infected women based on the high risk in the
excessively high TB incidence (more than 20-fold
higher) in HIV-infected infants.
Because scientists have improved techniques for isolat-
ing Mycobacterium tuberculosis in children and increas-
ing the yield, it is possible to identify the strains from
infected children, which can impact diagnosis and treat-
ment. Our team has developed a protein-enriched broth
that increases yield and decreases the time to detection.
Pediatric TB also offers an opportunity to look at the
emergence of drug resistant TB strains. In three DST sur-
veys conducted in Cape Town (1997 through 2007)
results indicated a significant increase in both drug and
multi-drug resistant cases of TB in children. Examination
of genotypes in 400 culture positive children showed the
most prevalent form to be the Beijing strain, thought to
have the greatest probability of progressing from TB
infection to disease and with distinct disease forms. Pro-
grams to prevent TB and TB/HIV co-infection in chil-
dren and adults must be improved; and safer vaccines,
better diagnostics and shorter treatment regimens devel-
oped targeting children.
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